Read more
10:54 AM · 3 November 2025

Morning wrap (03.11.2025)

  • Markets in Japan remain closed for Culture Day. Major currency pairs are trading within tight ranges. Investors are focusing on tomorrow’s RBA decision and today’s PMI and ISM data.

  • OPEC maintained its planned production increase of +137,000 barrels per day (in line with expectations) but announced a pause in hikes for Q1 2026 due to winter oversupply concerns — an unexpected shift that supported prices early in the week.

  • Fed Governor Waller voiced support for another rate cut in December, citing a weaker labor market and declining inflation despite macroeconomic uncertainty caused by the U.S. government shutdown.

  • He also added that he would accept a nomination for Fed Chair.

  • Trump ruled out sending Tomahawk missiles to Ukraine, hinted at “secret plans” for Venezuela, and said U.S. troops “could be deployed” in Nigeria.

  • He also mentioned that he meets regularly with Nvidia’s Jensen Huang and does not intend to share Blackwell chips abroad.

  • Melbourne Institute inflation rose to 3.1% y/y (remaining elevated), household spending increased +0.2% m/m (weak), building permits jumped +12%, while ANZ job ads fell −2.2% (fourth consecutive decline).

  • The RBA is likely to keep rates unchanged on Tuesday.

  • The manufacturing PMI for October fell from 50.7 to 49.4, signaling renewed weakness in the production sector.

  • The private manufacturing PMI dropped from 51.2 to 50.6. Domestic demand remained stable, but exports weakened amid tariff-related uncertainty.

24 April 2026, 9:53 PM

Daily summary: AI optimism, Nvidia stock surge & second round of US - Iran talks drive optimism on Wall Street

24 April 2026, 11:27 AM

Economic calendar: US UoM data in the spotlight (24.04.2026)

23 April 2026, 5:48 PM

BREAKING: US PMIs beat estimates 📈 Stocks back in the green

23 April 2026, 11:54 AM

💶European PMI Plunges as Iran Conflict Batters Economic Activity

The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.